Clinical Review
2015 Update on fertility
Egg freezing is no longer deemed “experimental.” Here are current protocols, fertility expectations, and safety outcomes as well as ethical...
Robert L. Barbieri, MD
Dr. Barbieri is Editor in Chief, OBG Management; Chair, Obstetrics and Gynecology, at Brigham and Women’s Hospital, Boston, Massachusetts; and Kate Macy Ladd Professor of Obstetrics, Gynecology, and Reproductive Biology at Harvard Medical School, Boston.
Dr. Barbieri reports no financial relationships relevant to this article.
Ethics. Uterus transplantation raises many bioethical concerns and programs need to engage biomedical ethicists to guide their activities. 11–13 Careful attention to thorough informed consent, risk-benefit analysis, equitable access, and fair selection of participants will be critical to running an ethical program. To reduce the risks of the procedure, programs likely will explore the use of uteri obtained from women who are brain dead or cadavers to spare altruistic living donors from undergoing hysterectomy surgery.
“Group of fools” or Nobel Prize in wait?
On December 23, 1954, the first successful kidney transplant was performed by Dr. Joseph E. Murray and his team at the Peter Bent Brigham Hospital, a predecessor to the Brigham and Women’s Hospital. 14 His small group of physicians worked for years to perfect the kidney transplantation technique in the laboratory prior to attempting the case. A key to their success was the decision to perform the transplant with identical twins as the donor and recipient.
In the 1950s there was great controversy about whether kidney transplantation was a medical breakthrough or surgical folly. The lead surgical team was referred to as the “group of fools” by some colleagues. But Dr. Murray and his team succeeded in their efforts and opened the field of solid organ transplant. Recognizing the importance of his accomplishment, the Nobel Prize Committee awarded Dr. Murray the 1990 Nobel Prize in Physiology or Medicine. Dr. E. Donnell Thomas, a co-recipient of the award, was simultaneously recognized for developing bone marrow transplantation as a treatment for leukemia.
A medical breakthrough…
Organ transplantation medicine initially focused on the treatment of life-threatening diseases, including kidney, heart, lung, and liver failure. With recent innovations in composite tissue transplants, including face and limb, transplantation medicine is evolving to expand its focus to the repair of functional deficits that are not life threatening but do significantly impact quality of life. Uterus transplantation is an example of the new era of using transplants to repair functional deficits. The clinicians and patients involved in these innovative programs are courageous pioneers opening new vistas and helping to realize previously impossible dreams. In our time, many stakeholders are likely to conclude that uterus transplantation is a surgical folly. However, I predict that our children will conclude that uterus transplantation represents a medical breakthrough.
Share your thoughts on this article! Send your Letter to the Editor to Please include your name and the city and state in which you practice.
Weigh in at the Quick Poll on the homepage. Send your answers to these cases and any comments to rbarbieri@frontlinemedcom.com . Please include your name and the city and state in which you practice.
Egg freezing is no longer deemed “experimental.” Here are current protocols, fertility expectations, and safety outcomes as well as ethical...
Large randomized trial data show that, although a safe treatment, the live-birth rate was lower with letrozole than with clomiphene or...
Cost pressures may bring more patients who report infertility to your office. Are your prepared to assess and treat these patients?
Three recent recommendations, on clomiphene, immunization, and postsurgical adhesions, may affect how you practice. These experts get to the heart...